BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Góralczyk A, Kolossa K, Waszczak-Jeka M, Adamczak R, Jeka S. The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. Postepy Dermatol Alergol 2020;37:306-12. [PMID: 32774212 DOI: 10.5114/ada.2020.96294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Thatiparthi A, Martin A, Liu J, Egeberg A, Wu JJ. Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. Am J Clin Dermatol 2021;22:425-42. [PMID: 33861409 DOI: 10.1007/s40257-021-00603-w] [Reference Citation Analysis]
2 Fernández-Sánchez M, Ribes-Artero H, Romá-Sánchez E, Gómez-Portero MR, Guerrero-Hurtado E, García-Pellicer J, Poveda-Andrés JL. Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report. Birth Defects Res 2021. [PMID: 34309233 DOI: 10.1002/bdr2.1942] [Reference Citation Analysis]